Zobrazeno 1 - 10 of 537 pro vyhledávání: '"JT Rutka"'
2
P.099 Generator replacement with cardiac based VNS device in children with drug-resistant epilepsy
Autor: A Hadjinicolaou, P Jain, I Yau, R Whitney, JT Rutka, CY Go
Publikováno v: Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 48:S47-S48
Background: We aimed to study the proportion of patients with DRE and pre-existing VNS device, who show improvement of at least one class in McHugh seizure outcome classification at last follow up after generator replacement with cardiac based VNS de
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e661996129ef2be96e82d1d58a98b890
https://doi.org/10.1017/cjn.2021.377
Zobrazit plný text záznamu
3
P.139 Pediatric posterior fossa ependymoma recurrence in a molecularly defined cohort – Clinical, demographic, and surgical factors associated with outcome
Autor: AK Malhotra, LF Nobre, GM Ibrahim, AV Kulkarni, JM Drake, JT Rutka, E Bouffet, MD Taylor, D Tsang, V Ramaswamy, MC Dewan, PB Dirks
Publikováno v: Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 49:S43-S43
Background: Pediatric posterior fossa ependymoma contributes to morbidity and mortality in children. Following gross total resection and adjuvant radiotherapy, there is a known risk of local recurrence that portends a dismal prognosis. We sought to c
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2f7e56029fd17c1ab97fbb10efcbecda
https://doi.org/10.1017/cjn.2022.223
Zobrazit plný text záznamu
4
C.06 Retraction of scientific publications in neurosurgery
Autor: NM Alotaibi, Jerry C. Ku, JZ Wang, JT Rutka
Publikováno v: Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 44:S13-S13
Background: Despite increasing awareness of scientific fraud, no attempt has been made to assess its prevalence in neurosurgery. The aim of our review was to assess the chronological trend and reasons for the retraction of neurosurgical publications.
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3c2082b786be78fa7f397f40626e2d96
https://doi.org/10.1017/cjn.2017.84
Zobrazit plný text záznamu
5
FSCN1 (fascin homolog 1, actin-bundling protein (Strongylocentrotus purpuratus))
Autor: CA Smith, JT Rutka, S Mondal, S Nagai
Publikováno v: Atlas of Genetics and Cytogenetics in Oncology and Haematology.
Review on FSCN1 (fascin homolog 1, actin-bundling protein (Strongylocentrotus purpuratus)), with data on DNA, on the protein encoded, and where the gene is implicated.
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::082aba89be5a16584e5136b14d1bb824
https://doi.org/10.4267/2042/44581
Zobrazit plný text záznamu
7
Akademický článek
Advances in neuro-oncology: contributions of the Asilomar Conference on brain tumor research and therapy.
Autor: Westphal M; 1Department of Neurosurgery, University Clinic Hamburg-Eppendorf (UKE), Hamburg, Germany., Levin VA; 2Department of Neuro-Oncology, MD Anderson Cancer Center, Houston, Texas., Berger MS; 3Department of Neurosurgery, University of California, San Francisco, California., Pieper R; 3Department of Neurosurgery, University of California, San Francisco, California., Nishikawa R; 4Department of Neurosurgery, Saitama Medical University, Saitama, Japan., Bjerkvig R; 5Department of Biomedicine, University of Bergen, Norway., Ashley DM; 6Departments of Neuro-Oncology and Neuropathology, Division of Pathology, Duke University Medical School, Durham, North Carolina., Bigner D; 6Departments of Neuro-Oncology and Neuropathology, Division of Pathology, Duke University Medical School, Durham, North Carolina., Sampson JH; 6Departments of Neuro-Oncology and Neuropathology, Division of Pathology, Duke University Medical School, Durham, North Carolina., Ichimura K; 7Department of Pathology, Kyorin University, Tokyo, Japan; and., Rutka JT; 8Department of Surgery, Division of Neurosurgery, The University of Toronto, Ontario, Canada.
Publikováno v: Journal of neurosurgery [J Neurosurg] 2024 Dec 20, pp. 1-7. Date of Electronic Publication: 2024 Dec 20.
Zobrazit plný text záznamu
8
Akademický článek
Convection-enhanced delivery of [ 177 Lu]Lu-labeled gold nanoparticles combined with anti-PD1 checkpoint immunotherapy improves the survival of immunocompetent C57BL/6J mice with orthotopic GL261 murine glioma tumors.
Autor: Georgiou CJ; Department of Pharmaceutical Sciences, University of Toronto, Toronto, ON, Canada., Brown MK; Department of Pharmaceutical Sciences, University of Toronto, Toronto, ON, Canada., Cai Z; Department of Pharmaceutical Sciences, University of Toronto, Toronto, ON, Canada., Alshafai L; Department of Medical Imaging, University of Toronto, Toronto, ON, Canada; Joint Department of Medical Imaging, Division of Neuroradiology, Mount Sinai Hospital and University Health Network, Toronto, ON, Canada., Gao A; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada; Laboratory Medicine Program, University Health Network, Toronto, ON, Canada., Rutka JT; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada; The Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, ON, Canada; Division of Neurosurgery, The Hospital for Sick Children, Toronto, ON, Canada., Winnik MA; Department of Chemistry, University of Toronto, Toronto, ON, Canada., Reilly RM; Department of Pharmaceutical Sciences, University of Toronto, Toronto, ON, Canada; Department of Medical Imaging, University of Toronto, Toronto, ON, Canada; Laboratory Medicine Program, University Health Network, Toronto, ON, Canada. Electronic address: raymond.reilly@utoronto.ca.
Publikováno v: Nuclear medicine and biology [Nucl Med Biol] 2024 Nov 09; Vol. 140-141, pp. 108970. Date of Electronic Publication: 2024 Nov 09.
Zobrazit plný text záznamu
9
Akademický článek
A kinome drug screen identifies multi-TKI synergies and ERBB2 signaling as a therapeutic vulnerability in MYC/TYR subgroup atypical teratoid rhabdoid tumors.
Autor: Golbourn B; John G. Rangos Sr. Research Center, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA.; Department of Neurological Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.; Cell Biology Research Program, The Hospital for Sick Children, Toronto, Ontario, Canada., Ho B; Department of Laboratory Medicine and Pathobiology, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.; Division of Hematology and Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada., Bondoc A; Cell Biology Research Program, The Hospital for Sick Children, Toronto, Ontario, Canada., Luck A; Cell Biology Research Program, The Hospital for Sick Children, Toronto, Ontario, Canada., Fan X; Cell Biology Research Program, The Hospital for Sick Children, Toronto, Ontario, Canada., Richardson E; Cell Biology Research Program, The Hospital for Sick Children, Toronto, Ontario, Canada., Marcellus R; Drug Discovery Program, Ontario Institute for Cancer Research, Toronto, Ontario, Canada., Prakesch M; Drug Discovery Program, Ontario Institute for Cancer Research, Toronto, Ontario, Canada., Halbert M; John G. Rangos Sr. Research Center, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA.; Department of Neurological Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA., Agrawal N; John G. Rangos Sr. Research Center, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA., Smith C; Cell Biology Research Program, The Hospital for Sick Children, Toronto, Ontario, Canada., Huang A; Department of Laboratory Medicine and Pathobiology, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.; Division of Hematology and Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada.; Department of Medical Biophysics, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.; Department of Pediatrics, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada., Rutka JT; Cell Biology Research Program, The Hospital for Sick Children, Toronto, Ontario, Canada.; Department of Laboratory Medicine and Pathobiology, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.; Division of Neurosurgery, The Hospital for Sick Children, Toronto, Ontario, Canada.
Publikováno v: Neuro-oncology [Neuro Oncol] 2024 Oct 03; Vol. 26 (10), pp. 1895-1911.
Zobrazit plný text záznamu
10
Akademický článek
CASCADES, a novel SOX2 super-enhancer-associated long noncoding RNA, regulates cancer stem cell specification and differentiation in glioblastoma.
Autor: Shahzad U; Faculty of Medicine, Institute of Medical Science, University of Toronto, Canada.; Arthur and Sonia Labatt Brain Tumor Research Center, Hospital for Sick Children, Toronto, Canada., Nikolopoulos M; Faculty of Medicine, Institute of Medical Science, University of Toronto, Canada.; Arthur and Sonia Labatt Brain Tumor Research Center, Hospital for Sick Children, Toronto, Canada., Li C; Arthur and Sonia Labatt Brain Tumor Research Center, Hospital for Sick Children, Toronto, Canada., Johnston M; Charbonneau Cancer Institute, Alberta Children's Hospital Research Institute (ACHRI), Department of Biochemistry and Molecular Biology, Cumming School of Medicine, University of Calgary, Canada., Wang JJ; Arthur and Sonia Labatt Brain Tumor Research Center, Hospital for Sick Children, Toronto, Canada., Sabha N; Program for Genetics and Genome Biology, Hospital for Sick Children, Toronto, Canada., Varn FS; The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA., Riemenschneider A; Faculty of Medicine, Institute of Medical Science, University of Toronto, Canada.; Arthur and Sonia Labatt Brain Tumor Research Center, Hospital for Sick Children, Toronto, Canada., Krumholtz S; Arthur and Sonia Labatt Brain Tumor Research Center, Hospital for Sick Children, Toronto, Canada., Krishnamurthy PM; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, USA., Smith CA; Arthur and Sonia Labatt Brain Tumor Research Center, Hospital for Sick Children, Toronto, Canada., Karamchandani J; Montreal Neurological Institute, McGill University Health Center (MUHC), Montreal, Canada., Watts JK; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, USA., Verhaak RGW; The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA., Gallo M; Charbonneau Cancer Institute, Alberta Children's Hospital Research Institute (ACHRI), Department of Biochemistry and Molecular Biology, Cumming School of Medicine, University of Calgary, Canada., Rutka JT; Faculty of Medicine, Institute of Medical Science, University of Toronto, Canada.; Arthur and Sonia Labatt Brain Tumor Research Center, Hospital for Sick Children, Toronto, Canada., Das S; Faculty of Medicine, Institute of Medical Science, University of Toronto, Canada.; Arthur and Sonia Labatt Brain Tumor Research Center, Hospital for Sick Children, Toronto, Canada.; Division of Neurosurgery, St. Michael's Hospital and Li Ka Shing Knowledge Institute, University of Toronto, Toronto, Canada.
Publikováno v: Molecular oncology [Mol Oncol] 2024 Sep 25. Date of Electronic Publication: 2024 Sep 25.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje